In this case, based on the Drosophila model,60 gpp/DOT1L appears to rather oppose NUP98-HOXA9 function, underscoring the need to critically evaluate the use of DOT1L inhibitors across cytogenetically different subtypes of leukemia. This evidence concerns the gene DOT1L and leukemia.